Ordog, T., Takayama, I., Cheung, W
(2000) Phe 13 ,Tyr 19 -Melanin-concentrating hormone and the blood-brain barrier: role of protein binding
The largest psychiatric safety meta-analysis to date found that GLP-1 medications were not associated with increased risk of serious psychiatric adverse events overall ( Pierret et al., JAMA Psychiatry, 2025 ), and a post-hoc analysis of the major semaglutide weight management trials found no differences in depression, suicidal ideation, or suicidal behavior compared to placebo ( Wadden et al., JAMA Internal Medicine, 2024 )
A nomenclature committee is suggested to create a clear and accessible system for naming and categorizing peptides, similar to what has been done in the field of genetics 4m10s
But she adds that these interactions are usually based on standard doses of naltrexone and not on LDN: In published LDN studies, concurrent use with most nonopioid medications has been well tolerated. Still, definitely tell your healthcare professional about everything you're takingmedications, supplements, even that random herbal tea you drinkbefore starting LDN
Rodent studies using metal oxide and silver nanoparticles have shown that high experimental doses of such materials can induce oxidative stress and inflammatory responses in the liver and gut, although these doses far exceed typical human dietary exposures (203207)